Raymond James Financial’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.3M Buy
493,248
+34,959
+8% +$6.43M 0.03% 609
2026
Q1
$86.4M Sell
458,289
-190,950
-29% -$40.2M 0.03% 567
2025
Q4
$129M Sell
649,239
-11,349
-2% -$2.29M 0.04% 406
2025
Q3
$134M Sell
660,588
-10,614
-2% -$1.88M 0.04% 391
2025
Q2
$118M Buy
671,202
+214,871
+47% +$32.3M 0.04% 418
2025
Q1
$61.4M Buy
456,331
+68,150
+18% +$8.97M 0.02% 622
2024
Q4
$49M Buy
+388,181
New +$57.7M 0.02% 733

Other funds holding THC

Raymond James Financial's THC Position: Q2 2026 in Review

Raymond James Financial increased its Tenet Healthcare (THC) stake by 7.6% in Q2 2026, buying an estimated $6.43M and bringing the position to 493,248 shares worth $92.3M. The position accounts for 0.03% of the portfolio, ranked #609.

Raymond James Financial first reported a position in THC in Q4 2024 and has held it in 7 quarters since. The position peaked at $134M in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Raymond James Financial held 493,248 shares of Tenet Healthcare worth $92.3M as of Q2 2026.
  • Raymond James Financial bought 34,959 Tenet Healthcare shares in Q2 2026, an estimated $6.43M.
  • Tenet Healthcare made up 0.03% of Raymond James Financial's portfolio in Q2 2026, its #609 holding.
  • Raymond James Financial first reported a position in Tenet Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Tenet Healthcare position peaked at $134M in Q3 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.